Pacific Capital Partners Ltd Makes New $1.08 Million Investment in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• Pacific Capital Partners Ltd has acquired a new stake in Prestige Consumer Healthcare Inc. during the first quarter, purchasing 12,500 shares valued at approximately $1,075,000.
• Several hedge funds have also adjusted their positions in Prestige Consumer Healthcare, with institutional investors owning nearly 99.95% of the company's stock.
• Analysts have given Prestige Consumer Healthcare a consensus rating of "Moderate Buy" with a target price of $93.33, indicating positive growth expectations for the stock.

Pacific Capital Partners Ltd purchased a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 12,500 shares of the company's stock, valued at approximately $1,075,000.

A number of other hedge funds have also recently made changes to their positions in PBH. Geode Capital Management LLC boosted its stake in Prestige Consumer Healthcare by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 1,348,745 shares of the company's stock valued at $105,342,000 after buying an additional 21,951 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC bought a new position in Prestige Consumer Healthcare during the fourth quarter valued at approximately $84,932,000. Invesco Ltd. boosted its stake in Prestige Consumer Healthcare by 2.4% during the fourth quarter. Invesco Ltd. now owns 1,060,263 shares of the company's stock valued at $82,796,000 after buying an additional 24,392 shares during the last quarter. Congress Asset Management Co. boosted its stake in Prestige Consumer Healthcare by 9.1% during the first quarter. Congress Asset Management Co. now owns 991,580 shares of the company's stock valued at $85,246,000 after buying an additional 82,838 shares during the last quarter. Finally, Northern Trust Corp lifted its stake in shares of Prestige Consumer Healthcare by 10.9% in the 4th quarter. Northern Trust Corp now owns 813,076 shares of the company's stock valued at $63,493,000 after purchasing an additional 80,055 shares during the last quarter. Institutional investors own 99.95% of the company's stock.

Analyst Upgrades and Downgrades

PBH has been the subject of several analyst reports. Wall Street Zen raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Royal Bank Of Canada raised Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $93.33.

Prestige Consumer Healthcare Trading Down 0.3%

Shares of NYSE PBH traded down $0.22 during midday trading on Friday, hitting $73.73. The company's stock had a trading volume of 423,917 shares, compared to its average volume of 406,596. The company has a current ratio of 4.20, a quick ratio of 2.82 and a debt-to-equity ratio of 0.55. The business's 50 day moving average is $80.65 and its two-hundred day moving average is $82.27. Prestige Consumer Healthcare Inc. has a 12-month low of $64.94 and a 12-month high of $90.04. The firm has a market cap of $3.64 billion, a P/E ratio of 17.19, a price-to-earnings-growth ratio of 2.22 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The firm had revenue of $296.52 million for the quarter, compared to the consensus estimate of $289.36 million. During the same period in the prior year, the business posted $1.02 earnings per share. The company's revenue for the quarter was up 7.0% on a year-over-year basis. As a group, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.